The role of drug-eluting balloons alone or in combination with drug-eluting stents in the treatment of de novo diffuse coronary disease

JACC: Cardiovascular Interventions

Volumn 6, Issue 11, 2013, Pages 1153-1159

  Costopoulos, Charis ^a,b,c   Latib, Azeem ^a,b   Naganuma, Toru ^a,b   Sticchi, Alessandro ^a   Figini, Filippo ^a   Basavarajaiah, Sandeep ^a,b,c   Carlino, Mauro ^a   Chieffo, Alaide ^a   Montorfano, Matteo ^a   Naim, Charbel ^a   Kawaguchi, Masanori ^a,b   Giannini, Francesco ^a   Colombo, Antonio ^a,b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b EMO GVM CENTRO CUORE COLUMBUS   (Italy)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

diffuse coronary artery disease; drug eluting balloon(s); drug eluting stent(s); target lesion revascularization

Indexed keywords

PACLITAXEL;

ADULT; AGED; ARTICLE; BALLOON; CAUSE OF DEATH; CELL PROLIFERATION; COHORT ANALYSIS; CORONARY ARTERY DISEASE; DRUG ELUTING BALLOON; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART DISEASE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; TARGET VESSEL REVASCULARIZATION;

CABG; CORONARY ARTERY BYPASS GRAFT; DAPT; DEB; DES; DIFFUSE CORONARY ARTERY DISEASE; DRUG-ELUTING BALLOON; DRUG-ELUTING STENT(S); DRUG-ELUTING BALLOON(S); DUAL ANTIPLATELET THERAPY; EES; EVEROLIMUS-ELUTING STENT(S); MACE; MAJOR ADVERSE CARDIAC EVENT(S); MI; MYOCARDIAL INFARCTION; PCI; PERCUTANEOUS CORONARY INTERVENTION; ST; STENT THROMBOSIS; TARGET LESION REVASCULARIZATION; TARGET VESSEL REVASCULARIZATION; TLR; TVR;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CARDIAC CATHETERS; CARDIOVASCULAR AGENTS; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; HOSPITALS, HIGH-VOLUME; HUMANS; ITALY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROSTHESIS DESIGN; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84888114173     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2013.07.005     Document Type: Article

References (21)

1. B. Scheller, C. Hehrlein, and W. Bocksch Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter N Engl J Med 355 2006 2113 2124
2. B. Scheller, C. Hehrlein, and W. Bocksch Two-year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter Clin Res Cardiol 97 2008 773 781
3. H. Rittger, J. Brachmann, and A.M. Sinha A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study J Am Coll Cardiol 59 2012 1377 1382
4. A. Latib, A. Colombo, and F. Castriota A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: the BELLO (Balloon Elution and Late Loss Optimization) study J Am Coll Cardiol 60 2012 2473 2480
5. D.L. Bhatt Intensifying platelet inhibition - navigating between Scylla and Charybdis N Engl J Med 357 2007 2078 2081
6. E. Camenzind, P.G. Steg, and W. Wijns Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern Circulation 115 2007 1440 1455
7. A. Colombo, and A. Latib Can long-term results following balloon angioplasty be the "crystal ball" to predict outcome following bioresorbable vascular scaffolds? J Am Heart Assoc 1 2012 e005272
8. S.H. Hofma, and W.J. van der Giessen Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation Eur Heart J 27 2006 166 167
9. C.W. Lee, D.W. Park, and B.K. Lee Predictors of restenosis after placement of drug-eluting stents in one or more coronary arteries Am J Cardiol 97 2006 506 511
10. F. D'Ascenzo, M. Bollati, and F. Clementi Incidence and predictors of coronary stent thrombosis: evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thromboses Int J Cardiol 167 2013 575 584
11. A.S. Sharp, A. Latib, and A. Ielasi Long-term follow-up on a large cohort of "full-metal jacket" percutaneous coronary intervention procedures Circ Cardiovasc Interv 2 2009 416 422
12. K. Thygesen, J.S. Alpert, and H.D. White Universal definition of myocardial infarction Circulation 116 2007 2634 2653
13. D.E. Cutlip, S. Windecker, and R. Mehran Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
14. S.A. Nashef, F. Roques, and P. Michel European system for cardiac operative risk evaluation (EuroSCORE) Eur J Cardiothorac Surg 16 1999 9 13
15. G. Sianos, M.A. Morel, and A.P. Kappetein The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease EuroIntervention 1 2005 219 227
16. S. Basavarajaiah, and A. Latib Drug elution without the need for stent struts and polymers: a promising technology? Interv Cardiol 4 2012 291 295
17. Sangiorgi G. Drug eluting balloons in very long and diffuse coronary artery disease. Paper presented at: EuroPCR; May 19, 2011; Paris, France.
18. Serra A. The Valentines II trial. Paper presented at: Cardiovascular Research Technologies; February 7, 2012; Washington, DC.
19. P.W. Serruys, P. de Jaegere, and F. Kiemeneij A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group N Engl J Med 331 1994 489 495
20. D.W. Park, Y.H. Kim, and H.G. Song Comparison of everolimus- and sirolimus-eluting stents in patients with long coronary artery lesions: a randomized LONG-DES-III (Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-III) Trial J Am Coll Cardiol Intv 4 2011 1096 1103
21. B.E. Claessen, P.C. Smits, and D.J. Kereiakes Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials J Am Coll Cardiol Intv 4 2011 1209 1215